At ALCMI, we are dedicated to advancing the understanding and treatment of lung cancer through innovative clinical trials. We specialize in remote, decentralized, observational biospecimen studies. We're particularly interested in trials related to young lung cancer, resistance mechanisms, and hereditary risk factors. 

Our current clinical trials are designed to explore novel diagnostics, targeted therapies, and early detection methods, all of which aim to improve patient outcomes and quality of life.

Here are our current open trials.